Category | Term | Count | % | p | Fold enrichment | FDR |
---|---|---|---|---|---|---|
GOTERM_BP_FAT | GO:0006952 defence response | 25 | 13.4 | 6.00E-07 | 3.25 | 0.001 |
GO:0042060 wound healing | 14 | 7.5 | 7.37E-07 | 5.87 | 0.001 | |
GO:0042127 regulation of cell proliferation | 28 | 15.1 | 1.37E-06 | 2.85 | 0.002 | |
GO:0006955 immune response | 25 | 13.4 | 4.51E-06 | 2.90 | 0.008 | |
GO:0006928 cell motion | 20 | 10.8 | 6.96E-06 | 3.37 | 0.012 | |
GOTERM_CC_FAT | GO:0005576 extracellular region | 49 | 26.3 | 1.88E-07 | 2.12 | 0.000 |
GO:0044421 extracellular region part | 29 | 15.6 | 3.41E-06 | 2.63 | 0.004 | |
GO:0005615 extracellular space | 23 | 12.4 | 1.01E-05 | 2.92 | 0.013 | |
GO:0000267 cell fraction | 27 | 14.5 | 2.17E-04 | 2.17 | 0.275 | |
GO:0005625 soluble fraction | 13 | 7.0 | 2.48E-04 | 3.61 | 0.314 | |
GOTERM_MF_FAT | GO:0004857 enzyme inhibitor activity | 13 | 7.0 | 7.39E-05 | 4.11 | 0.101 |
GO:0032395 MHC class II receptor activity | 4 | 2.2 | 0.001303 | 17.98 | 1.768 | |
GO:0004866 endopeptidase inhibitor activity | 8 | 4.3 | 0.001519 | 4.71 | 2.058 | |
GO:0030414 peptidase inhibitor activity | 8 | 4.3 | 0.002074 | 4.47 | 2.800 | |
GO:0005520 insulin-like growth factor binding | 4 | 2.2 | 0.00294 | 13.67 | 3.947 | |
KEGG_PATHWAY | hsa05332: Graft-versus-host disease | 8 | 4.3 | 2.41E-06 | 12.42 | 0.003 |
hsa04940: Type I diabetes mellitus | 8 | 4.3 | 4.07E-06 | 11.53 | 0.004 | |
hsa05330: Allograft rejection | 7 | 3.8 | 2.08E-05 | 11.77 | 0.023 | |
hsa04610: Complement and coagulation cascades | 8 | 4.3 | 1.14E-04 | 7.02 | 0.126 | |
hsa05416: Viral myocarditis | 8 | 4.3 | 1.37E-04 | 6.82 | 0.151 | |
UP_TISSUE | Lung | 52 | 28.0 | 5.15E-07 | 2.03 | 0.001 |